MARKET

CRNX

CRNX

Crinetics Pharmaceuticals
NASDAQ

Real-time Quotes | Nasdaq Last Sale

16.62
+0.14
+0.85%
Closed 16:41 10/14 EDT
OPEN
16.45
PREV CLOSE
16.48
HIGH
17.06
LOW
16.14
VOLUME
23.20K
TURNOVER
--
52 WEEK HIGH
36.95
52 WEEK LOW
14.33
MARKET CAP
365.77M
P/E (TTM)
-10.7302
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CRNX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CRNX News

  • Crinetics Pharmaceuticals to Participate in Cantor Global Healthcare Conference
  • GlobeNewswire.09/25 12:30
  • The Daily Biotech Pulse: PhaseBio Leaps On Trial Results, Pacira Set To Join SmallCap 600 Index, Positive Readout For Amgen's Blood Cancer Drug
  • Benzinga.09/25 11:13
  • What Makes Crinetics Pharmaceuticals (CRNX) a Strong Sell?
  • Zacks.09/12 13:40
  • Crinetics Pharmaceuticals (CRNX) Investor Presentation - Slideshow
  • Seeking Alpha - Article.09/10 16:12

More

Industry

Biotechnology & Medical Research
+0.42%
Pharmaceuticals & Medical Research
+0.09%

Hot Stocks

Name
Price
%Change

About CRNX

Crinetics Pharmaceuticals, Inc. is a clinical stage pharmaceutical company. The Company is focused on the discovery and development of drugs to treat specialty endocrine diseases and endocrine-related tumors. It develops a pipeline of oral nonpeptide chemical entities that target peptide G protein coupled receptors (GPCRs) for the treatment of endocrine diseases. The Company’s lead product candidate is CRN00808 developed for the treatment of acromegaly. It also develops two other product candidates CRN02481 for hyperinsulinemia, and CRN01941 for the treatment of neuroendocrine tumors. CRN02481 and CRN01941 are both oral nonpeptide somastatin receptors that are in the pre-clinical stages of development. The company also conducts research programs on developing nonpeptide products for the treatment of Cushing’s disease.
More

Webull offers Crinetics Pharmaceuticals Inc (CRNX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.